These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7741187)

  • 1. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
    Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
    Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5.
    Zeck-Kapp G; Czech W; Kapp A
    Exp Dermatol; 1994 Aug; 3(4):176-88. PubMed ID: 8000707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
    Kapp A; Zeck-Kapp G; Czech W; Schöpf E
    J Invest Dermatol; 1994 Jun; 102(6):906-14. PubMed ID: 7516398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degranulation from human eosinophils stimulated with C3a and C5a.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A; Tenor H; Schudt C
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.
    Rot A; Krieger M; Brunner T; Bischoff SC; Schall TJ; Dahinden CA
    J Exp Med; 1992 Dec; 176(6):1489-95. PubMed ID: 1281207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
    Takafuji S; Tadokoro K; Ito K
    Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
    Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
    Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of eosinophil cytokine generation by chemoattractants.
    Miyamasu M; Hirai K; Takahashi Y; Iida M; Ohtoshi T; Takaishi T; Morita Y; Ohta K; Ito K; Kasahara T
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():12-5. PubMed ID: 7549512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils.
    Thomet OA; Wiesmann UN; Blaser K; Simon HU
    Clin Exp Allergy; 2001 Aug; 31(8):1310-20. PubMed ID: 11529903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors.
    Fujiu T; Kato M; Kimura H; Tachibana A; Suzuki M; Nako Y; Morikawa A
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):90-8. PubMed ID: 12141728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein.
    Tenscher K; Metzner B; Schöpf E; Norgauer J; Czech W
    Blood; 1996 Oct; 88(8):3195-9. PubMed ID: 8874220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of degranulation from human eosinophils by platelet-activating factor.
    Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
    J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils.
    Dichmann S; Idzko M; Zimpfer U; Hofmann C; Ferrari D; Luttmann W; Virchow C; Di Virgilio F; Norgauer J
    Blood; 2000 Feb; 95(3):973-8. PubMed ID: 10648411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation.
    Ezeamuzie CI; Al-Hage M
    Int Arch Allergy Immunol; 1998 Feb; 115(2):162-8. PubMed ID: 9482706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.
    Moy JN; Gleich GJ; Thomas LL
    J Immunol; 1990 Oct; 145(8):2626-32. PubMed ID: 2170521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.